// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Patient priorities in osteoporosis research: generating meaningful research questions

Ashley Hawarden - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

Safety and efficacy of subcutaneous tocilizumab in patients with systemic and polyarticular juvenile idiopathic arthritis

Athimalaipet V Ramanan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Glucocorticoid

Tree of life workshop: an innovative approach to engaging young people with JIA and their parents and carers

Sangeeta Sawlani Ramos - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Utility, feasibility and acceptability of quantitative MRI in children with juvenile idiopathic arthritis

Joshua L Bennett - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

Five years of public patient involvement and engagement (PPI/E) at the Arthritis Research UK Centre for Adolescent Rheumatology at UCL, UCLH and GOSH

James Wilton - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Developing an allied health core outcome set for paediatric rheumatology musculoskeletal conditions

Victoria Harbottle - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Integrating peer support for young people and parents into routine practice

Stephanie Vale - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Destructive ankle disease treated by surgical arthodiastasis with an Ilizarov frame in a cohort of children and young people with juvenile idiopathic arthritis

Cleary Gavin - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

The self- and shared-management of juvenile idiopathic arthritis by children, young people, families and professionals involved in their healthcare and education: reflections from a patient-led, realist evaluation

Simon R Stones - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

The use of certolizumab pegol to manage women with active juvenile idiopathic arthritis in pregnancy and whilst brestfeeding

Martin A Lee - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Certolizumab pegol

How common is methotrexate intolerance in juvenile idiopathic arthritis?

Mohammad Saad Khan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Does the quality & outcomes framework (QOF) indicator for osteoporosis work? A primary care study

Sultana Parvin - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

The link between health literacy, consultation behaviour and musculoskeletal health in people with knee pain

Alaina Hadfield - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

The outcomes of triaging rheumatology referrals at a single point of access

Bethan Forgie - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Early inflammatory arthritis

N/A

Measuring the impact of musculoskeletal disorders, with and without other morbidities, on stopping work before state pension age: a retrospective nested case-control study

Stephen J Duffield - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rheumatoid Exercise and Fatigue Group (REAF): an audit

Faye L Tonepohl - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Shared medical appointments as an alternative to individual annual review in inflammatory arthritis

Jessica Ellis - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Exeter GCA fast track pathway: 12 month results

Mahdi Abusalameh - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The impact of a fast track pathway for giant cell arthritis

Jonathan Pinnell - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

A nurse-led biologic dose tapering programme in patients with rheumatoid arthritis

Marianne Loke - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Adalimumab

Copyright © 2026. QuantiNova All rights reserved